Table 3. Cox regression analysis comparing all-cause mortality after-propensity-score matching.
Variable | Univariate analysis | Multivariate analysis | ||
HR (95% CI) | P value | HR (95% CHR) | P value | |
Age | 1.02 (1.01 to 1.03) | <0.001 | 1.02 (1.01 to 1.03) | <0.001 |
Sex | 1.00 (0.85 to 1.19) | 0.96 | 0.87 (0.73 to 1.04) | 0.125 |
Metastatic disease | 1.24 (1.04 to 1.48) | 0.017 | 1.24 (1.04 to 1.48) | 0.018 |
ICI type | 0.99 (0.95 to 1.02) | 0.49 | 0.96 (0.93 to 1.00) | 0.045 |
BMI≥25 | 0.71 (0.60 to 0.84) | <0.001 | 0.71 (0.60 to 0.84) | <0.001 |
T2DM | 1.71 (1.20 to 2.43) | 0.003 | 1.58 (1.08 to 2.31) | 0.019 |
Hypertension | 1.26 (1.05 to 1.51) | 0.011 | 0.91 (0.73 to 1.14) | 0.42 |
Heart failure | 2.10 (1.45 to 3.04) | <0.001 | 1.30 (0.85 to 1.98) | 0.22 |
Hyperlipidemia | 1.13 (0.93 to 1.37) | 0.21 | 0.85 (0.68 to 1.07) | 0.162 |
Chronic kidney disease | 2.00 (1.41 to 2.85) | <0.001 | 1.35 (0.91 to 1.99) | 0.135 |
COPD | 1.27 (0.85 to 1.90) | 0.24 | 1.05 (0.69 to 1.60) | 0.81 |
Ischemic heart disease | 0.76 (0.19 to 3.06) | 0.70 | 0.52 (0.12 to 2.20) | 0.37 |
BMI unit: kg/m2.
COPD, chronic obstructive pulmonary disease; ICI, immune checkpoint inhibitorT2DM, type 2 diabetes mellitus